# matrix_ceo/management/commands/seed_eternal_matrix.py
from django.core.management.base import BaseCommand
from django.contrib.auth.models import User
from matrix_ceo.models import CorporateBoard, StrategicProject
from django.utils import timezone
import random

class Command(BaseCommand):
    help = 'Seed eternal matrix with strategic projects'

    def handle(self, *args, **options):
        self.stdout.write('Seeding Eternal Matrix data...')
        
        # Create Corporate Board
        board, created = CorporateBoard.objects.get_or_create(
            name="Next Star Strategic Governance Board",
            defaults={
                'description': 'Oversight board for executive-level project selection and CEO governance',
                'governance_token': 'NEXT-STAR-GOV-2024'
            }
        )
        
        # Create Strategic Projects
        strategic_projects = [
            {
                'name': 'Quantum Neural Interface Corporation',
                'domain': 'AI',
                'vision_statement': 'Pioneering the next generation of human-AI symbiosis through advanced non-invasive neural interfaces that enhance cognitive capabilities while maintaining ethical boundaries and human agency.',
                'mission_objectives': [
                    'Develop non-invasive BCI with 95% accuracy by 2026',
                    'Establish comprehensive ethical framework for human augmentation',
                    'Secure FDA approval for medical rehabilitation applications',
                    'Build developer ecosystem with 1000+ applications by 2027'
                ],
                'success_metrics': {
                    'user_adoption': '1M+ active users by 2027',
                    'revenue_growth': '$500M ARR by 2028',
                    'innovation_index': '50+ patents filed annually',
                    'safety_rating': '99.99% uptime with zero critical failures'
                },
                'ceo_compensation': {
                    'equity_shares': 1500000,
                    'base_salary': 450000,
                    'performance_bonus': 'up to 200% of base',
                    'long_term_incentives': 'stock options vesting over 4 years'
                },
                'strategic_challenges': [
                    'Navigating evolving neurotech regulations across 50+ countries',
                    'Addressing ethical concerns about cognitive enhancement',
                    'Competing with tech giants entering the neurotech space',
                    'Attracting and retaining specialized neuroscience talent'
                ],
                'critical_decisions': [
                    'Build proprietary hardware vs partner with existing manufacturers',
                    'Focus on medical applications first vs direct-to-consumer',
                    'Open source the API ecosystem vs keep proprietary',
                    'Global expansion timing and market prioritization'
                ],
                'risk_factors': {
                    'regulatory': 'Very High - Unclear neurotech regulations',
                    'technical': 'Extreme - Unproven technology at scale',
                    'market': 'High - Unclear consumer demand patterns',
                    'ethical': 'Extreme - Public perception and moral concerns'
                },
                'complexity': 'executive'
            },
            {
                'name': 'Decentralized Autonomous Energy Grid',
                'domain': 'Blockchain',
                'vision_statement': 'Democratizing energy distribution through blockchain-enabled community microgrids that empower local communities, accelerate renewable adoption, and create resilient energy infrastructure.',
                'mission_objectives': [
                    'Deploy 1000+ community microgrids across 50 countries by 2027',
                    'Achieve 40% reduction in energy costs for participating communities',
                    'Integrate 5GW of renewable capacity into the network',
                    'Establish token-based energy trading as industry standard'
                ],
                'success_metrics': {
                    'grid_reliability': '99.99% uptime across entire network',
                    'cost_reduction': '30-50% lower than traditional utilities',
                    'renewable_adoption': '80% of energy from renewable sources',
                    'community_impact': '500K+ households served with clean energy'
                },
                'ceo_compensation': {
                    'equity_shares': 1200000,
                    'base_salary': 380000,
                    'performance_bonus': 'up to 150% of base',
                    'impact_bonus': 'tied to renewable adoption and community metrics'
                },
                'strategic_challenges': [
                    'Navigating legacy utility regulations and political resistance',
                    'Securing infrastructure funding at global scale',
                    'Managing decentralized governance of energy assets',
                    'Ensuring grid stability with intermittent renewable sources'
                ],
                'critical_decisions': [
                    'Prioritize developed markets vs emerging economies',
                    'Balance community control vs operational efficiency needs',
                    'Select technology stack for 20-year scalability',
                    'Partnership strategy with existing energy providers'
                ],
                'risk_factors': {
                    'regulatory': 'Extreme - Utilities are heavily regulated',
                    'technical': 'Very High - Integrating legacy and modern systems',
                    'financial': 'Very High - Capital intensive infrastructure',
                    'political': 'High - Energy is politically sensitive worldwide'
                },
                'complexity': 'senior'
            },
            {
                'name': 'Synthetic Biology Therapeutics Platform',
                'domain': 'Biotech',
                'vision_statement': 'Revolutionizing medicine through programmable biology and synthetic therapeutics that address previously untreatable genetic conditions with personalized, cost-effective solutions.',
                'mission_objectives': [
                    'Develop 10 novel synthetic biology therapies by 2028',
                    'Reduce gene therapy costs by 80% through platform approach',
                    'Achieve regulatory approval in US, EU, and Asian markets',
                    'Build automated manufacturing for personalized therapies'
                ],
                'success_metrics': {
                    'patient_impact': 'Treat 50,000+ patients by 2030',
                    'cost_efficiency': '80% reduction in therapy costs',
                    'regulatory_success': '3+ major market approvals by 2027',
                    'innovation_pipeline': '20+ therapies in development'
                },
                'ceo_compensation': {
                    'equity_shares': 1800000,
                    'base_salary': 520000,
                    'performance_bonus': 'up to 250% of base',
                    'milestone_bonuses': 'tied to regulatory and clinical successes'
                },
                'strategic_challenges': [
                    'Navigating complex FDA and international regulatory pathways',
                    'Managing ethical concerns around genetic engineering',
                    'Securing long-term funding for clinical trials',
                    'Building manufacturing at scale for personalized medicine'
                ],
                'critical_decisions': [
                    'Focus on rare diseases vs common conditions first',
                    'Build vs partner for clinical trial capabilities',
                    'IP strategy: patent broadly vs open science approach',
                    'Pricing model for global accessibility vs profitability'
                ],
                'risk_factors': {
                    'regulatory': 'Extreme - Evolving genetic medicine regulations',
                    'technical': 'Very High - Unproven at commercial scale',
                    'ethical': 'Very High - Public concerns about genetic engineering',
                    'clinical': 'High - Uncertain trial outcomes'
                },
                'complexity': 'executive'
            }
        ]

        for project_data in strategic_projects:
            project, created = StrategicProject.objects.get_or_create(
                name=project_data['name'],
                board=board,
                defaults=project_data
            )
            
            if created:
                project.approve_project()
                self.stdout.write(self.style.SUCCESS(f'Created strategic project: {project.name}'))

        self.stdout.write(self.style.SUCCESS('\n🎯 Eternal Matrix seeding complete!'))
        self.print_summary()

    def print_summary(self):
        self.stdout.write('\n' + '='*60)
        self.stdout.write('ETERNAL MATRIX STRATEGIC PROJECTS SUMMARY')
        self.stdout.write('='*60)
        
        projects = StrategicProject.objects.all()
        for project in projects:
            self.stdout.write(f"\n📊 {project.name}")
            self.stdout.write(f"   Domain: {project.domain}")
            self.stdout.write(f"   Status: {project.get_status_display()}")
            self.stdout.write(f"   Complexity: {project.get_complexity_display()}")
            self.stdout.write(f"   CEO Compensation: {project.ceo_compensation['equity_shares']:,} shares + ${project.ceo_compensation['base_salary']:,}")
            
        self.stdout.write(f"\n🌌 READY FOR CEO CANDIDATES:")
        self.stdout.write(f"   Total Projects: {projects.count()}")
        self.stdout.write(f"   Executive Level: {projects.filter(complexity='executive').count()}")
        self.stdout.write(f"   Senior Level: {projects.filter(complexity='senior').count()}")